Sightera Biosciences has raised €3 million in a pre-seed funding round led by Entourage, Anacura and QBIC to expand its patient-derived AI drug discovery platform.
Amount Raised
€3 Million
Round Type
Pre-Seed
BelgiumBiotechnologyHealth CareArtificial IntelligenceTherapeuticsInvestors
Description
Sightera Biosciences, a Belgian techbio company, has closed a €3 million pre-seed funding round. The funding will support the expansion of its AI-powered drug discovery platform and accelerate development of its preclinical pipeline. Sightera focuses on oncology and fibrosis using proprietary patient-derived datasets. The company plans to enhance collaborations with pharmaceutical and biotechnology firms and grow its research teams.
Quick answer
Sightera Biosciences raised €3 Million in a Pre-Seed round, dated July 17, 2026. Investors: Entourage, Anacura and Qbic. Sightera Biosciences is based in Belgium.
- How much did Sightera Biosciences raise?
- Sightera Biosciences raised €3 Million in a Pre-Seed round on July 17, 2026.
- Who invested in Sightera Biosciences?
- Entourage, Anacura and Qbic are named as investors in this round.
- What does Sightera Biosciences do?
- Sightera Biosciences is a Belgian techbio company utilizing generative AI to develop novel small-molecule therapies.
- Where is Sightera Biosciences based and how big is it?
- Sightera Biosciences is based in Belgium. Fundz records about 6 employees.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Sightera Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Transcripta Bio raised $24M (Series A) on July 22, 2026.
- AbSci Corp raised $40M (Funding Round) on July 1, 2026.
- Graph Therapeutics raised $5M (Funding Round) on June 22, 2026.
- EIT Pharma raised $35M (Series A) on August 31, 2026.
- PANDA Therapeutics raised $185K (Pre-Seed) on August 31, 2026.
- Clementine raised $2M (Seed) on August 28, 2026.
Who to call at Sightera Biosciences, and when
A new round usually means Sightera Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Sightera Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sightera Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sightera Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sightera Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Sightera Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.